ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 51 filers reported holding ORCHARD THERAPEUTICS PLC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $2,963,323 | -25.8% | 7,987,396 | 0.0% | 0.79% | -26.5% |
Q3 2022 | $3,994,000 | +28.8% | 7,987,396 | +50.5% | 1.07% | -9.3% |
Q2 2022 | $3,101,000 | -17.9% | 5,307,751 | 0.0% | 1.18% | -26.3% |
Q1 2022 | $3,779,000 | -55.6% | 5,307,751 | -17.7% | 1.61% | -43.1% |
Q4 2021 | $8,514,000 | -9.3% | 6,449,856 | +58.0% | 2.83% | +3.1% |
Q3 2021 | $9,388,000 | -47.6% | 4,081,972 | 0.0% | 2.74% | -34.3% |
Q2 2021 | $17,919,000 | -39.1% | 4,081,972 | +0.7% | 4.17% | -29.2% |
Q1 2021 | $29,417,000 | +132.3% | 4,051,972 | +38.2% | 5.89% | +65.1% |
Q4 2020 | $12,663,000 | +5.1% | 2,931,185 | 0.0% | 3.57% | -16.8% |
Q3 2020 | $12,047,000 | -31.5% | 2,931,185 | 0.0% | 4.29% | -37.5% |
Q2 2020 | $17,587,000 | -21.2% | 2,931,185 | -1.0% | 6.86% | -86.9% |
Q1 2020 | $22,306,000 | -45.2% | 2,962,267 | +0.1% | 52.57% | +71.3% |
Q4 2019 | $40,679,000 | +14.5% | 2,958,492 | -1.1% | 30.68% | -11.3% |
Q3 2019 | $35,524,000 | – | 2,990,211 | – | 34.58% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CHI Advisors LLC | 4,081,972 | $9,388,000 | 2.74% |
RA Capital Management | 11,028,722 | $25,366,000 | 0.35% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $15,984,000 | 0.31% |
Avidity Partners Management LP | 3,836,798 | $8,825,000 | 0.20% |
Casdin Capital, LLC | 2,575,000 | $5,923,000 | 0.15% |
Vivo Capital, LLC | 1,325,736 | $3,049,000 | 0.14% |
Artal Group S.A. | 1,803,858 | $4,149,000 | 0.09% |
Eversept Partners, LP | 569,581 | $1,310,036 | 0.09% |
GSA CAPITAL PARTNERS LLP | 374,811 | $862,000 | 0.09% |
PLATINUM INVESTMENT MANAGEMENT LTD | 1,078,315 | $2,480,000 | 0.07% |